X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-09 | GERN | Lawlis V Bryan | Dir | P - Purchase | $1.18 | +13,300 | 13,300 | New | +$15,667 | ||||||
2025-02-27 | GERN | Samuels Scott Alan | EVP, GC | P - Purchase | $1.61 | +15,000 | 26,682 | +128% | +$24,150 | ||||||
2025-02-27 | GERN | Scarlett John A | COB, Pres, CEO | P - Purchase | $1.77 | +12,500 | 137,500 | +10% | +$22,063 | ||||||
2025-02-27 | GERN | Ziegler James | EVP, Chief Commercial Officer | P - Purchase | $1.60 | +100,000 | 100,000 | New | +$160,000 | ||||||
| D | 2024-07-08 | GERN | Grethlein Andrew J | EVP, COO | S - Sale+OE | $4.56 | -674,348 | 0 | -100% | -$3,073,004 | |||||
| D | 2024-06-10 | GERN | Feller Faye | EVP, Chief Medical Officer | S - Sale+OE | $4.63 | -287,900 | 0 | -100% | -$1,334,129 | |||||
| D | 2024-06-10 | GERN | Kapur Anil | EVP, Corp Strategy, CCO | S - Sale+OE | $4.65 | -421,875 | 0 | -100% | -$1,959,609 | |||||
| D | 2024-06-04 | GERN | Scarlett John A | COB, Pres, CEO | S - Sale+OE | $4.00 | -600,000 | 600,000 | -50% | -$2,400,000 | |||||
| D | 2024-05-15 | GERN | Lawlis V Bryan | Dir | S - Sale+OE | $3.75 | -35,000 | 0 | -100% | -$131,250 | |||||
2023-08-24 | GERN | O'Farrell Elizabeth G. | Dir | P - Purchase | $2.28 | +13,186 | 33,627 | +65% | +$30,064 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |